星空体育注册官网|正牌大公司

You Position: Home > Paper

Use of an indirect cohort design for evaluation of vaccine effectiveness

( views:2, downloads:0 )

Author:: No author available

Journal Title:: Chinese Journal of Vaccines and Immunization

Issue:: 2

DOI:: 10.19914/j.CJVI.2024041

Key Word:: 间接队列设计;疫苗;保护效果;Indirect cohort design;Vaccine;Vaccine effectiveness

Abstract： Post-marketing vaccine effectiveness(VE)evaluation is an epidemiological assessment of vaccinations to prevent and control diseases in the real world.The indirect cohort design(ICD)is a study design that uses individual-level vaccination history data and infecting pathogen serotypes of patients with vaccine-targeted diseases to calculate VE.An ICD can effectively reduce sample size,lower study cost,and retain high credibility.In this article,we review principles,post-marketing VE evaluations,and advantages and limitations of ICD,aiming to help researchers better understand and conduct ICD VE evaluations.

Reference

[1]彭向东,徐瑶瑶,胡晓江,等.2013-2023年上海市60岁及以上老年人23价肺炎球菌多糖疫苗免费接种情况及效果分析[J].2023,4(4).
[2]毛雯雯,李靖琳,姜晓飞,等.北京市丰台区老年人免费23价肺炎球菌多糖疫苗接种影响因素分析[J].2023,17(3).
[3]巫婷,刘珏.检测阴性设计：基本原理、方法、衍生设计、优劣势及应用[J].2022,25(36).
[4]Sugaya, Norio,Shinjoh, Masayoshi,Nakata, Yuji,etc.Three-season effectiveness of inactivated influenza vaccine in preventing influenza illness and hospitalization in children in Japan, 2013-2016[J].2018,36(8).
[5]Randle E,Ninis N,Inwald D.Invasive pneumococcal disease.[J].2011,96(5).
[6]Marc Rondy,Nathalie El Omeiri,Mark G. Thompson,etc.Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies[J].2017,75(5).
[7]Weinberger DM,Malley R,Lipsitch M.Serotype replacement in disease after pneumococcal vaccination.[J].2011,378(9807).
[8]Jari J. Hirvonen,Tapio Seiskari,Inka Harju,etc.Use of an automated PCR assay, the GenomEra S. pneumoniae, for rapid detection of Streptococcus pneumoniae in blood cultures[J].2015,47(11).
[9]Petrosky, Emiko,Bocchini Jr, Joseph A.,Hariri, Susan,etc.Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices.[J].2015,64(11).
[10]J C, Butler,R F, Breiman,J F, Campbell,etc.Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations.[J].1993,270(15).
[11]中华预防医学会,中华预防医学会疫苗与免疫分会.肺炎球菌性疾病免疫预防专家共识（2020版）[J].2021,(1).
[12]De Serres, Gaston,Pilishvili, Tamara,Link-Gelles, Ruth,etc.Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period[J].2012,30(27).
[13]Miller, Elizabeth,Andrews, Nicholas J.,Waight, Pauline A.,etc.Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine[J].2011,29(49).
[14]Leeming JP,Cartwright K,Morris R,etc.Diagnosis of invasive pneumococcal infection by serotype-specific urinary antigen detection.[J].2005,43(10).
[15]Andrews, Nick,Waight, Pauline A.,Borrow, Ray,etc.Using the Indirect Cohort Design to Estimate the Effectiveness of the Seven Valent Pneumococcal Conjugate Vaccine in England and Wales.[J].2011,6(12).
[16]张力,金鹏飞,李靖欣,等.检测阴性设计在疫苗效果评价中的应用[J].2020,(2).
[17]Kaoru Araki,Megumi Hara,Chisato Shimanoe,etc.Case-Control Study of Rotavirus Vaccine Effectiveness Compared to Test-Negative Controls or Hospital Controls[J].2019,29(8).
[18].Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: A cross-sectional study[J].2011,8(4).
[19]C V, Broome,R R, Facklam,D W, Fraser.Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine.[J].1980,303(10).
[20]Belongia, Edward A.,King, Jennifer P.,Sundaram, Maria E.,etc.Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies[J].2016,16(8).
[21]Ying Chen,Wei Deng,Song-Mei Wang,etc.Burden of Pneumonia and Meningitis Caused by Streptococcus pneumoniae in China among Children under 5 Years of Age: A Systematic Literature Review.[J].2011,6(11).
[22]徐娟,邓景景,栾琳,等.2017-2020年苏州市地方扩大免疫规划项目实施情况报告[J].2022,38(11).
[23]Cooper, David,Yu, Xinhong,Sidhu, Mohinder,etc.The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A[J].2011,29(41).
[24].Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: The indirect cohort design, 2006-2018[J].2019,37(32).
[25]Werno AM,Murdoch DR.Medical microbiology: laboratory diagnosis of invasive pneumococcal disease.[J].2008,46(6).
[26]Andrews,N.J.,Waight,P.A.,Burbidge,P.,etc.Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: A postlicensure indirect cohort study[J].2014,14(9).
[27]SanjayJayasinghe,ClaytonChiu,HelenQuinn,etc.Effectiveness of 7- and 13-Valent Pneumococcal Conjugate Vaccines in a Schedule Without a Booster Dose: A 10-Year Observational Study[J].2018,67(3).
[28]Rueckinger, Simon,van der Linden, Mark,Reinert, Ralf Rene,etc.Efficacy of 7-valent pneumococcal conjugate vaccination in Germany: An analysis using the indirect cohort method[J].2010,28(31).